pith. sign in

arxiv: 2605.21083 · v1 · pith:OBUCIB36new · submitted 2026-05-20 · ⚛️ physics.app-ph · cs.LG· physics.bio-ph· physics.med-ph

AIMBio-Mat: An AI-Native FAIR Platform for Closed-Loop Materials Discovery and Biomedical Translation

D.-M. Mei , K. Acharya , C. M. Adhikari , M. Adhikari , S. Aryal , B. V. Benson , K. Bhatta , S. Bhattarai
show 46 more authors
N. Budhathoki A. M. Castillo D. Chakraborty S. Chhetri S. Choudhury T. A. Chowdhury R. D. Cruz B. Cui S. Dhital K.-M. Dong R. Gapuz A. Ghasemi E. Z. Gnimpieba B. D. S. Gurung H. A. Hashim R. I. Harry K.-E. Hasin M. K. Hassanzadeh M. K. Jha D. Kim K.-C. Kong B. Lama A. Mahat N. Maharjan A. Majeed J. Mammo M. M. Masud K. S. Moore A. Nawaz H. Oli S. A. Panamaldeniya L. Pandey R. Pandey Z. Peng A. Prem M. M. Rana K. Rana Magar R. Rizk C. S. Tadi L.-W. Wang Y. Yang G.-L. Yin C.-X. Yu D. Zeng M. Zhou Q. Zhou
This is my paper

Pith reviewed 2026-05-21 01:49 UTC · model grok-4.3

classification ⚛️ physics.app-ph cs.LGphysics.bio-phphysics.med-ph
keywords materials discoverybiomedical translationAI-native platformFAIR datamulti-objective optimizationknowledge graphsactive learninggovernance
0
0 comments X

The pith

AIMBio blueprint couples fragmented materials and biomedical records into auditable AI-guided discovery workflows under uncertainty.

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The paper presents AIMBio as a conceptual framework for an AI-native, FAIR platform that links materials provenance with biomedical contexts through knowledge graphs and active learning. It formulates discovery as constrained multi-objective optimization under uncertainty and specifies practical requirements for metadata standards, model documentation, risk-tiered governance, and evaluation metrics. A minimum viable prototype specification and a worked pilot on AI-guided nanomaterials for drug delivery make the approach testable. The work positions the platform as exploratory preclinical infrastructure, not clinical software, to support translationally responsible workflows from data to experiments.

Core claim

AIMBio is a governance-aware decision layer that connects materials and biomedical data ecosystems via knowledge graphs, uncertainty-aware machine learning, and human-in-the-loop active learning to support closed-loop, translationally responsible materials discovery formulated as constrained multi-objective optimization under uncertainty, with requirements for metadata, model documentation, risk-tiered governance, evaluation metrics, and phased implementation.

What carries the argument

Constrained multi-objective optimization under uncertainty, carried by metadata standards, model documentation, risk-tiered governance, knowledge graphs, and human-in-the-loop active learning.

If this is right

  • Enables conversion of fragmented records into auditable and experimentally actionable workflows.
  • Supports phased implementation starting from a minimum viable prototype.
  • Provides a concrete pilot example for nanomaterials in drug delivery.
  • Clarifies boundaries between exploratory use and any future regulated clinical applications.

Where Pith is reading between the lines

These are editorial extensions of the paper, not claims the author makes directly.

  • The same coupling approach could extend to other fragmented domains such as energy storage materials.
  • Adoption would likely depend on compatibility with existing public materials databases and knowledge graphs.
  • Running the prototype on additional pilot cases could surface specific bottlenecks in uncertainty quantification.

Load-bearing premise

Existing materials and biomedical data ecosystems can be practically coupled via metadata standards, model documentation, risk-tiered governance, and evaluation metrics to support constrained multi-objective optimization under uncertainty.

What would settle it

A working pilot that fails to couple the data ecosystems through the specified metadata and governance structures, or that produces no experimentally actionable nanomaterial candidates meeting the multi-objective criteria within the uncertainty bounds.

Figures

Figures reproduced from arXiv: 2605.21083 by A. Ghasemi, A. Mahat, A. Majeed, A. M. Castillo, A. Nawaz, A. Prem, B. Cui, B. D. S. Gurung, B. Lama, B. V. Benson, C. M. Adhikari, C. S. Tadi, C.-X. Yu, D. Chakraborty, D. Kim, D.-M. Mei, D. Zeng, E. Z. Gnimpieba, G.-L. Yin, H. A. Hashim, H. Oli, J. Mammo, K. Acharya, K. Bhatta, K.-C. Kong, K.-E. Hasin, K.-M. Dong, K. Rana Magar, K. S. Moore, L. Pandey, L.-W. Wang, M. Adhikari, M. K. Hassanzadeh, M. K. Jha, M. M. Masud, M. M. Rana, M. Zhou, N. Budhathoki, N. Maharjan, Q. Zhou, R. D. Cruz, R. Gapuz, R. I. Harry, R. Pandey, R. Rizk, S. A. Panamaldeniya, S. Aryal, S. Bhattarai, S. Chhetri, S. Choudhury, S. Dhital, T. A. Chowdhury, Y. Yang, Z. Peng.

Figure 1
Figure 1. Figure 1: Publication-oriented architecture of AIMBio-Mat. Heterogeneous materials and biomedical [PITH_FULL_IMAGE:figures/full_fig_p010_1.png] view at source ↗
Figure 2
Figure 2. Figure 2: Publication-oriented knowledge-graph structure for AIMBio-Mat. The diagram separates [PITH_FULL_IMAGE:figures/full_fig_p012_2.png] view at source ↗
Figure 3
Figure 3. Figure 3: Design–build–test–learn cycle implemented by the closed-loop discovery layer. The system [PITH_FULL_IMAGE:figures/full_fig_p013_3.png] view at source ↗
Figure 4
Figure 4. Figure 4: Closed-loop drug-delivery nanoparticle pilot. The platform selects candidate batches [PITH_FULL_IMAGE:figures/full_fig_p019_4.png] view at source ↗
read the original abstract

Materials discovery and biomedical translation increasingly require models that can reason across composition, processing, structure, biological response, manufacturability, safety, and governance constraints. Existing materials and biomedical data ecosystems are powerful but remain poorly coupled for AI-guided discovery. Here we present AIMBio, a conceptual framework for an AI-native, FAIR, and governance-aware decision layer that links materials provenance, biomedical context, knowledge graphs, uncertainty-aware machine learning, and human-in-the-loop active learning. The framework formulates biomedical-materials discovery as constrained multi-objective optimization under uncertainty and introduces practical requirements for metadata, model documentation, risk-tiered governance, evaluation metrics, and phased implementation. To make the roadmap testable, we add a minimum viable prototype specification and a worked pilot for AI-guided nanomaterials for drug delivery. AIMBio is positioned as exploratory and preclinical discovery infrastructure, not as clinical decision-support software; any clinical or regulated-device use would require separate validation, change control, and regulatory review. The central contribution is a publishable platform blueprint for converting fragmented materials and biomedical records into auditable, experimentally actionable, and translationally responsible discovery workflows.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, simulated authors' rebuttal, and a circularity audit. Tearing a paper down is the easy half of reading it; the pith above is the substance, this is the friction.

Referee Report

2 major / 2 minor

Summary. The manuscript proposes AIMBio-Mat, an AI-native FAIR platform for closed-loop materials discovery and biomedical translation. It introduces a conceptual framework that links materials provenance, biomedical context, knowledge graphs, uncertainty-aware machine learning, and human-in-the-loop active learning to formulate discovery as constrained multi-objective optimization under uncertainty. The paper outlines practical requirements for metadata, model documentation, risk-tiered governance, evaluation metrics, and phased implementation, supported by a minimum viable prototype specification and a worked pilot example for AI-guided nanomaterials for drug delivery. The central contribution is positioned as a blueprint for auditable and translationally responsible discovery workflows.

Significance. If the proposed couplings and governance mechanisms can be realized, the framework would offer a structured approach to integrating materials and biomedical data for AI-guided discovery while incorporating uncertainty and regulatory considerations. This addresses a recognized gap in fragmented ecosystems. The significance is tempered by the absence of empirical validation or detailed resolution of implementation barriers, limiting immediate translational impact.

major comments (2)
  1. [Minimum viable prototype specification] Minimum viable prototype specification: The blueprint asserts that metadata standards, model documentation, risk-tiered governance, and evaluation metrics enable constrained multi-objective optimization under uncertainty, yet provides no concrete mechanisms for resolving domain-specific interoperability issues such as mismatched ontologies between materials and biomedical records or provenance tracking across privacy regimes; this assumption is load-bearing for the central claim of converting fragmented records into auditable workflows.
  2. [Worked pilot] Worked pilot for AI-guided nanomaterials for drug delivery: The pilot is described at a high level without quantitative metrics, uncertainty quantification details, or demonstration of how the decision layer handles conflicting objectives (e.g., efficacy vs. safety), leaving the optimization formulation untested within the manuscript's scope.
minor comments (2)
  1. [Abstract] The abstract and framework description would benefit from a schematic diagram illustrating the data flow between the knowledge graph, ML models, and governance layer to improve clarity of the proposed architecture.
  2. [Framework Description] Notation for the 'AIMBio decision layer' is introduced without explicit definition or pseudocode; adding a formal description would aid reproducibility of the conceptual model.

Simulated Author's Rebuttal

2 responses · 0 unresolved

We thank the referee for the constructive and detailed review of our manuscript on the AIMBio-Mat framework. We address each major comment point by point below, providing clarifications on the conceptual scope of the work and outlining targeted revisions to strengthen the presentation.

read point-by-point responses

  1. Referee: [Minimum viable prototype specification] Minimum viable prototype specification: The blueprint asserts that metadata standards, model documentation, risk-tiered governance, and evaluation metrics enable constrained multi-objective optimization under uncertainty, yet provides no concrete mechanisms for resolving domain-specific interoperability issues such as mismatched ontologies between materials and biomedical records or provenance tracking across privacy regimes; this assumption is load-bearing for the central claim of converting fragmented records into auditable workflows.

    Authors: We agree that interoperability challenges, including ontology mismatches and cross-regime provenance tracking, are critical for practical realization. The manuscript is explicitly framed as a conceptual blueprint rather than a deployed system, with the MVP specification intended to define necessary components at a requirements level. The central claim concerns the overall structure enabling auditable workflows, with the understanding that specific technical resolutions would be addressed in implementation phases by domain experts. To strengthen the manuscript, we will revise the MVP section to reference established approaches for ontology alignment (e.g., from materials informatics and biomedical standards) and privacy-preserving provenance methods (e.g., federated or differential privacy techniques), while clarifying that these are illustrative pathways rather than exhaustive solutions. revision: partial

  2. Referee: [Worked pilot] Worked pilot for AI-guided nanomaterials for drug delivery: The pilot is described at a high level without quantitative metrics, uncertainty quantification details, or demonstration of how the decision layer handles conflicting objectives (e.g., efficacy vs. safety), leaving the optimization formulation untested within the manuscript's scope.

    Authors: The worked pilot is presented as a hypothetical illustration to demonstrate integration of the framework elements in a representative use case, consistent with the paper's role as an exploratory blueprint rather than an empirical validation study. We concur that expanding on the optimization details would improve clarity. In the revision, we will augment the pilot section with a more explicit description of the constrained multi-objective formulation, including example handling of trade-offs (e.g., via Pareto fronts or weighted objectives under Bayesian uncertainty quantification) and illustrative metrics drawn from the described scenario. This will better articulate the decision layer without introducing new empirical data or claiming tested performance. revision: partial

Circularity Check

0 steps flagged

No circularity: conceptual blueprint remains self-contained

full rationale

The paper presents a high-level conceptual framework and platform blueprint for coupling materials and biomedical data ecosystems via metadata standards, governance, and multi-objective optimization. No equations, fitted parameters, predictions, or derivations are present that could reduce to inputs by construction. The central claims rest on stated requirements and a minimum viable prototype specification rather than self-referential logic or load-bearing self-citations. The proposal draws on prior concepts in FAIR data and AI-guided discovery but does not derive its assertions circularly from them, making the contribution independent of any internal reduction.

Axiom & Free-Parameter Ledger

0 free parameters · 1 axioms · 1 invented entities

The central claim rests on domain assumptions about data coupling and the feasibility of governance integration; no free parameters or invented physical entities are introduced, but the AIMBio layer itself is postulated as the linking mechanism.

axioms (1)
  • domain assumption Existing materials and biomedical data ecosystems are powerful but remain poorly coupled for AI-guided discovery.
    Directly stated in the abstract as the motivation and starting point for the proposed framework.
invented entities (1)
  • AIMBio decision layer no independent evidence
    purpose: Links materials provenance, biomedical context, knowledge graphs, uncertainty-aware machine learning, and human-in-the-loop active learning for constrained optimization.
    Introduced as the core conceptual component without independent falsifiable evidence provided in the abstract.

pith-pipeline@v0.9.0 · 6036 in / 1335 out tokens · 124064 ms · 2026-05-21T01:49:57.859586+00:00 · methodology

discussion (0)

Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.

Lean theorems connected to this paper

Citations machine-checked in the Pith Canon. Every link opens the source theorem in the public Lean library.

What do these tags mean?
matches
The paper's claim is directly supported by a theorem in the formal canon.
supports
The theorem supports part of the paper's argument, but the paper may add assumptions or extra steps.
extends
The paper goes beyond the formal theorem; the theorem is a base layer rather than the whole result.
uses
The paper appears to rely on the theorem as machinery.
contradicts
The paper's claim conflicts with a theorem or certificate in the canon.
unclear
Pith found a possible connection, but the passage is too broad, indirect, or ambiguous to say the theorem truly supports the claim.

Reference graph

Works this paper leans on

59 extracted references · 59 canonical work pages

  1. [1]

    Anubhav Jain, Shyue Ping Ong, Geoffroy Hautier, Wei Chen, William Davidson Richards, Stephen Dacek, Shreyas Cholia, Dan Gunter, David Skinner, Gerbrand Ceder, and Kristin A. Persson. Commentary: The Materials Project: A Materials Genome Approach to Accelerating Materials Innovation.APL Materials, 1(1):011002, 2013. doi: 10.1063/1.4812323. URL https://doi....

    work page doi:10.1063/1.4812323 2013

  2. [2]

    Saal, Bryce Meredig, Alex Thompson, Jeff W

    Scott Kirklin, James E. Saal, Bryce Meredig, Alex Thompson, Jeff W. Doak, Muratahan Aykol, Stephan R¨ uhl, and Chris Wolverton. The Open Quantum Materials Database (OQMD): Assessing the Accuracy of DFT Formation Energies.npj Computational Materials, 1:15010,

    work page

  3. [3]

    URL https://doi.org/10.1038/npjcompumats .2015.10

    doi: 10.1038/npjcompumats.2015.10. URL https://doi.org/10.1038/npjcompumats .2015.10

    work page doi:10.1038/npjcompumats.2015.10 2015

  4. [4]

    Stefano Curtarolo, Wahyu Setyawan, Gus L. W. Hart, Michal Jahnatek, Roman V. Chepulskii, Richard H. Taylor, Shidong Wang, Junkai Xue, Kesong Yang, Ohad Levy, Michael J. Mehl, Harold T. Stokes, Denis O. Demchenko, and Dane Morgan. AFLOW: An Automatic Framework for High-Throughput Materials Discovery.Computational Materials Science, 58:218–226, 2012. doi: 1...

    work page doi:10.1016/j.commatsci.2012.02.005 2012

  5. [5]

    Butler, Daniel W

    Keith T. Butler, Daniel W. Davies, Hugh Cartwright, Olexandr Isayev, and Aron Walsh. Machine Learning for Molecular and Materials Science.Nature, 559(7715):547–555, 2018. doi: 10.1038/s41586-018-0337-2. URLhttps://doi.org/10.1038/s41586-018-0337-2

    work page doi:10.1038/s41586-018-0337-2 2018

  6. [6]

    Inverse Molecular Design Using Machine Learning: Generative Models for Matter Engineering.Science, 361(6400):360–365, 2018

    Benjamin Sanchez-Lengeling and Al´ an Aspuru-Guzik. Inverse Molecular Design Using Machine Learning: Generative Models for Matter Engineering.Science, 361(6400):360–365, 2018. doi: 10.1126/science.aat2663. URLhttps://doi.org/10.1126/science.aat2663

    work page doi:10.1126/science.aat2663 2018

  7. [7]

    Persson, Gerbrand Ceder, and Anubhav Jain

    Vahe Tshitoyan, John Dagdelen, Leigh Weston, Alexander Dunn, Ziqin Rong, Olga Kononova, Kristin A. Persson, Gerbrand Ceder, and Anubhav Jain. Unsupervised Word Embeddings Capture Latent Knowledge from Materials Science Literature.Nature, 571:95–98, 2019. doi: 10.1038/s41586-019-1335-8. URLhttps://doi.org/10.1038/s41586-019-1335-8

    work page doi:10.1038/s41586-019-1335-8 2019

  8. [8]

    Schoenholz, Muratahan Aykol, Gowoon Cheon, and Ekin D

    Amil Merchant, Simon Batzner, Samuel S. Schoenholz, Muratahan Aykol, Gowoon Cheon, and Ekin D. Cubuk. Scaling Deep Learning for Materials Discovery.Nature, 624(7990):80–85, 2023. doi: 10.1038/s41586-023-06735-9. URLhttps://doi.org/10.1038/s41586-023-06735-9

    work page doi:10.1038/s41586-023-06735-9 2023

  9. [9]

    Gilad Kusne, Hongpeng Yu, Cheng-Ju Wu, Hongbo Zhang, Jason Hattrick-Simpers, Brian DeCost, S

    A. Gilad Kusne, Hongpeng Yu, Cheng-Ju Wu, Hongbo Zhang, Jason Hattrick-Simpers, Brian DeCost, S. K. Sarker, Corey Oses, Cormac Toher, Stefano Curtarolo, Albert V. Davydov, Ritesh Agarwal, Leonid A. Bendersky, Mo Li, Apurva Mehta, and Ichiro Takeuchi. On-the-fly Closed-loop Materials Discovery via Bayesian Active Learning.Nature Communications, 11: 5966, 2...

    work page doi:10.1038/s41467-020-19597-w 2020

  10. [10]

    Gilad Kusne, Jason Hattrick-Simpers, Keith A

    Eric Stach, Brian DeCost, A. Gilad Kusne, Jason Hattrick-Simpers, Keith A. Brown, Karina G. Reyes, Joshua Schrier, Simon J. L. Billinge, Tonio Buonassisi, Ian Foster, et al. Autonomous 30 Experimentation Systems for Materials Development: A Community Perspective.Matter, 4(9): 2702–2726, 2021. doi: 10.1016/j.matt.2021.06.036. URL https://doi.org/10.1016/j....

    work page doi:10.1016/j.matt.2021.06.036 2021

  11. [11]

    Self-Driving Laboratories for Chemistry and Materials Science.Chemical Reviews, 2024

    Gary Tom et al. Self-Driving Laboratories for Chemistry and Materials Science.Chemical Reviews, 2024. doi: 10.1021/acs.chemrev.4c00055. URL https://doi.org/10.1021/acs.ch emrev.4c00055

    work page doi:10.1021/acs.chemrev.4c00055 2024

  12. [12]

    Szymanski, B

    N.J. Szymanski, B. Rendy, Y. Fei, et al. An autonomous laboratory for the accelerated synthesis of inorganic materials.Nature, 624:86–91, 2023. doi: 10.1038/s41586-023-06734-w. URL https://doi.org/10.1038/s41586-023-06734-w

    work page doi:10.1038/s41586-023-06734-w 2023

  13. [13]

    Shoemaker, Paul A

    Sunghwan Kim, Jie Chen, Tiejun Cheng, Asta Gindulyte, Jia He, Siqian He, Qingliang Li, Benjamin A. Shoemaker, Paul A. Thiessen, Bo Yu, Leonid Zaslavsky, Jian Zhang, and Evan E. Bolton. PubChem 2023 Update.Nucleic Acids Research, 51(D1):D1373–D1380, 2023. doi: 10.1093/nar/gkac956. URLhttps://doi.org/10.1093/nar/gkac956

    work page doi:10.1093/nar/gkac956 2023

  14. [14]

    Sayers, Jeff Beck, Evan E

    Eric W. Sayers, Jeff Beck, Evan E. Bolton, J. Rodney Brister, Kathi Canese, Donald C. Comeau, Karen Funk, Amy Ketter, Sunghwan Kim, Avi Kimchi, Paul A. Kitts, Alexander Kuznetsov, Melissa J. Landrum, Zhiyong Lu, Aron Marchler-Bauer, Terence Murphy, Nuala O’Leary, Lon Phan, Sanjida H. Rangwala, Valerie A. Schneider, Yuri Skripchenko, Bart W. Trawick, Kim D...

    work page doi:10.1093/nar/gkae1114 2025

  15. [15]

    Nature , author =

    John Jumper, Richard Evans, Alexander Pritzel, Tim Green, Michael Figurnov, Olaf Ronneberger, Kathryn Tunyasuvunakool, Russ Bates, Augustin Zidek, Anna Potapenko, et al. Highly Accurate Protein Structure Prediction with AlphaFold.Nature, 596:583–589, 2021. doi: 10.1038/s41586-021-03819-2. URLhttps://doi.org/10.1038/s41586-021-03819-2

    work page doi:10.1038/s41586-021-03819-2 2021

  16. [16]

    URL https://www.nature.com/articles/ s41586-024-07487-w

    Josh Abramson, Jonas Adler, Jack Dunger, Richard Evans, Tim Green, Alexander Pritzel, Olaf Ronneberger, Lindsay Willmore, Andrew J. Ballard, Joshua Bambrick, Sebastian W. Bodenstein, David A. Evans, Chia-Chun Hung, Michael O’Neill, David Reiman, Kathryn Tunyasuvunakool, Zachary Wu, et al. Accurate Structure Prediction of Biomolecular Interactions with Alp...

    work page doi:10.1038/s41586-024-07487-w 2024

  17. [17]

    Applications of Machine Learning in Drug Discovery and Development.Nature Reviews Drug Discovery, 18:463–477, 2019

    Jessica Vamathevan, Dominic Clark, Paul Czodrowski, Ian Dunham, Edgardo Ferran, George Lee, Bin Li, Anant Madabhushi, Parantu Shah, Michaela Spitzer, and Shanrong Zhao. Applications of Machine Learning in Drug Discovery and Development.Nature Reviews Drug Discovery, 18:463–477, 2019. doi: 10.1038/s41573-019-0024-5. URL https://doi.org/10.1038/s41573-019-0024-5

    work page doi:10.1038/s41573-019-0024-5 2019

  18. [18]

    Eric J. Topol. High-Performance Medicine: The Convergence of Human and Artificial Intelligence.Nature Medicine, 25:44–56, 2019. doi: 10.1038/s41591-018-0300-7. URL https://doi.org/10.1038/s41591-018-0300-7

    work page doi:10.1038/s41591-018-0300-7 2019

  19. [19]

    A Guide to Deep Learning in Healthcare.Nature Medicine, 25:24–29, 2019

    Andre Esteva, Alexandre Robicquet, Bharath Ramsundar, Volodymyr Kuleshov, Mark DePristo, Katherine Chou, Claire Cui, Greg Corrado, Sebastian Thrun, and Jeff Dean. A Guide to Deep Learning in Healthcare.Nature Medicine, 25:24–29, 2019. doi: 10.1038/s41591-018-0316-z. URLhttps://doi.org/10.1038/s41591-018-0316-z. 31

    work page doi:10.1038/s41591-018-0316-z 2019

  20. [20]

    Workshop for AI-Powered Materials Discovery at Great Plains,

    University of South Dakota. Workshop for AI-Powered Materials Discovery at Great Plains,

    work page

  21. [21]

    Held June 22–25, 2025, at the University of South Dakota

    URL https://aimaterialsworkshop.org/event/1/ . Held June 22–25, 2025, at the University of South Dakota

    work page 2025

  22. [22]

    Wilkinson, Michel Dumontier, IJsbrand Jan Aalbersberg, Gabrielle Appleton, Myles Axton, Arie Baak, Niklas Blomberg, Jan-Willem Boiten, Luiz Bonino da Silva Santos, Philip E

    Mark D. Wilkinson, Michel Dumontier, IJsbrand Jan Aalbersberg, Gabrielle Appleton, Myles Axton, Arie Baak, Niklas Blomberg, Jan-Willem Boiten, Luiz Bonino da Silva Santos, Philip E. Bourne, et al. The FAIR Guiding Principles for Scientific Data Management and Stewardship. Scientific Data, 3:160018, 2016. doi: 10.1038/sdata.2016.18. URL https://doi.org/10....

    work page doi:10.1038/sdata.2016.18 2016

  23. [23]

    Downs, Rorie Edmunds, David Giaretta, Marisa De Giusti, Herv´ e L’Hours, Wim Hugo, Reyna Jenkyns, Varsha Khodiyar, Maryann E

    Dawei Lin, Jonathan Crabtree, Ingrid Dillo, Robert R. Downs, Rorie Edmunds, David Giaretta, Marisa De Giusti, Herv´ e L’Hours, Wim Hugo, Reyna Jenkyns, Varsha Khodiyar, Maryann E. Martone, Mustapha Mokrane, Vivek Navale, Jonathan Petters, Barbara Sierman, Dina V. Sokolova, Martina Stockhause, and John Westbrook. The TRUST Principles for Digital Repositori...

    work page doi:10.1038/s41597-020-0486-7 2020

  24. [24]

    Figueroa-Rodr´ ıguez, Jarita Holbrook, Raymond Lovett, Simeon Materechera, Mark Parsons, Kay Raseroka, Desi Rodriguez-Lonebear, Robyn Rowe, Rodrigo Sara, Jennifer D

    Stephanie Russo Carroll, Ibrahim Garba, Oscar L. Figueroa-Rodr´ ıguez, Jarita Holbrook, Raymond Lovett, Simeon Materechera, Mark Parsons, Kay Raseroka, Desi Rodriguez-Lonebear, Robyn Rowe, Rodrigo Sara, Jennifer D. Walker, Jane Anderson, and Maui Hudson. The CARE Principles for Indigenous Data Governance.Data Science Journal, 19(1):43, 2020. doi: 10.5334/...

    work page doi:10.5334/dsj-2020-043 2020

  25. [25]

    PROV-O: The PROV Ontology

    Timothy Lebo, Satya Sahoo, Deborah McGuinness, Khalid Belhajjame, James Cheney, David Corsar, Daniel Garijo, Stian Soiland-Reyes, Stephan Zednik, and Jun Zhao. PROV-O: The PROV Ontology. W3C Recommendation, 2013. URL https://www.w3.org/TR/prov-o/ . World Wide Web Consortium

    work page 2013

  26. [26]

    ACM64, 12 (Dec

    Timnit Gebru, Jamie Morgenstern, Briana Vecchione, Jennifer Wortman Vaughan, Hanna Wallach, Hal Daum´ e III, and Kate Crawford. Datasheets for Datasets.Communications of the ACM, 64(12):86–92, 2021. doi: 10.1145/3458723. URLhttps://doi.org/10.1145/3458723

    work page doi:10.1145/3458723 2021

  27. [27]

    Selbst, danah boyd, Sorelle A

    Margaret Mitchell, Simone Wu, Andrew Zaldivar, Parker Barnes, Lucy Vasserman, Ben Hutchinson, Elena Spitzer, Inioluwa Deborah Raji, and Timnit Gebru. Model Cards for Model Reporting. InProceedings of the Conference on Fairness, Accountability, and Transparency, pages 220–229. Association for Computing Machinery, 2019. doi: 10.1145/3287560.3287596. URLhttp...

    work page doi:10.1145/3287560.3287596 2019

  28. [28]

    Ball, Helen C

    Alvis Brazma, Pascal Hingamp, John Quackenbush, Gavin Sherlock, Paul Spellman, Christian Stoeckert, John Aach, Wilhelm Ansorge, Catherine A. Ball, Helen C. Causton, Terry Gaasterland, Patrick Glenisson, Frank C. P. Holstege, Irene F. Kim, Victor Markowitz, John C. Matese, Helen Parkinson, Alan Robinson, Ugis Sarkans, Steffen Schulze-Kremer, Jason Stewart,...

    work page

  29. [29]

    URLhttps://doi.org/10.1038/ng1201-365

    doi: 10.1038/ng1201-365. URLhttps://doi.org/10.1038/ng1201-365

    work page doi:10.1038/ng1201-365

  30. [30]

    Evelo, Martin J

    Susanna-Assunta Sansone, Philippe Rocca-Serra, Dawn Field, Eamonn Maguire, Chris Taylor, Oliver Hofmann, Hong Fang, Steffen Neumann, Weida Tong, Linda Amaral-Zettler, Kimberly Begley, Tim Booth, Lydie Bougueleret, Gareth Burns, Brad Chapman, Tim Clark, Lee-Anne Coleman, John Copeland, Sudeshna Das, Antoine de Daruvar, Paula de Matos, Ian Dix, Scott Edmund...

    work page doi:10.1038/ng.1054 2012

  31. [31]

    Balachandran, Dezhen Xue, and Ruihao Yuan

    Turab Lookman, Prasanna V. Balachandran, Dezhen Xue, and Ruihao Yuan. Active Learning in Materials Science with Emphasis on Adaptive Sampling Using Uncertainties for Targeted Design.npj Computational Materials, 5:21, 2019. doi: 10.1038/s41524-019-0153-8. URL https://doi.org/10.1038/s41524-019-0153-8

    work page doi:10.1038/s41524-019-0153-8 2019

  32. [32]

    Autonomous Efficient Experiment Design for Materials Discovery with Bayesian Model Averaging.Physical Review Materials, 2:113803, 2018

    Anjana Talapatra, Shouyan Boluki, Ta Duong, Xiaoning Qian, Edward Dougherty, and Raymundo Arr´ oyave. Autonomous Efficient Experiment Design for Materials Discovery with Bayesian Model Averaging.Physical Review Materials, 2:113803, 2018. doi: 10.1103/PhysRe vMaterials.2.113803. URLhttps://doi.org/10.1103/PhysRevMaterials.2.113803

    work page doi:10.1103/physre 2018

  33. [33]

    Food and Drug Administration

    U.S. Food and Drug Administration. Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. FDA Action Plan, 2021. URL https: //www.fda.gov/media/145022/download. Accessed 28 April, 2026

    work page 2021

  34. [34]

    Food and Drug Administration

    U.S. Food and Drug Administration. Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions. FDA Guidance Document, 2025. URL https://www.fda.gov/regulatory -information/search-fda-guidance-documents/marketing-submission-recommendatio ns-predetermined-change-control-plan-art...

    work page 2025

  35. [35]

    Calvert, and Alastair K

    Xiaoxuan Liu, Samantha Cruz Rivera, David Moher, Melanie J. Calvert, and Alastair K. Denniston. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension.Nature Medicine, 26:1364–1374, 2020. doi: 10.1038/ s41591-020-1034-x. URLhttps://doi.org/10.1038/s41591-020-1034-x

    work page doi:10.1038/s41591-020-1034-x 2020

  36. [36]

    Denniston, and Melanie J

    Samantha Cruz Rivera, Xiaoxuan Liu, An-Wen Chan, Alastair K. Denniston, and Melanie J. Calvert. Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension.Nature Medicine, 26:1351–1363, 2020. doi: 10.1038/s41591-020-103 7-7. URLhttps://doi.org/10.1038/s41591-020-1037-7

    work page doi:10.1038/s41591-020-103 2020

  37. [37]

    FHIR Release 4: Fast Healthcare Interoperability Resources

    HL7 International. FHIR Release 4: Fast Healthcare Interoperability Resources. Health Level Seven International standard, 2019. URLhttps://www.hl7.org/fhir/

    work page 2019

  38. [38]

    Digital Imaging and Communications in Medicine (DICOM) Standard

    National Electrical Manufacturers Association. Digital Imaging and Communications in Medicine (DICOM) Standard. DICOM Standard, 2025. URL https://www.dicomstandard. org/current/

    work page 2025

  39. [39]

    Fern´ andez, Daniel Garijo, Bj¨ orn Gr¨ uning, Marco La Rosa, Simone Leo, Eoghan´O Carrag´ ain, Marc Portier, Ana Trisovic, RO-Crate Community, et al

    Stian Soiland-Reyes, Peter Sefton, Merc` e Crosas, Leyla Jael Castro, Frederik Coppens, Jos´ e M. Fern´ andez, Daniel Garijo, Bj¨ orn Gr¨ uning, Marco La Rosa, Simone Leo, Eoghan´O Carrag´ ain, Marc Portier, Ana Trisovic, RO-Crate Community, et al. Packaging research artefacts with RO-Crate.Data Science, 5(2):97–138, 2022. doi: 10.3233/DS-210053. URL http...

    work page doi:10.3233/ds-210053 2022

  40. [40]

    Peter Amstutz, Michael R. Crusoe, Nebojˇ sa Tijani´ c, Brad Chapman, John Chilton, Michael Heuer, Andrey Kartashov, Dan Leehr, Herv´ e M´ enager, Maya Nedeljkovich, Matt Scales, Stian Soiland-Reyes, and Luka Stojanovic. Common Workflow Language, v1.0. Specification, 2016. URLhttps://doi.org/10.6084/m9.figshare.3115156.v2

    work page doi:10.6084/m9.figshare.3115156.v2 2016

  41. [41]

    The Unified Medical Language System (UMLS): integrating biomedical terminology.Nucleic Acids Research, 32(Database issue):D267–D270, 2004

    Olivier Bodenreider. The Unified Medical Language System (UMLS): integrating biomedical terminology.Nucleic Acids Research, 32(Database issue):D267–D270, 2004. doi: 10.1093/nar/ gkh061. URLhttps://doi.org/10.1093/nar/gkh061

    work page doi:10.1093/nar/ 2004

  42. [42]

    Munteanu, Christoph Steinbeck, and Egon L

    Janna Hastings, Nina Jeliazkova, Gareth Owen, Georgia Tsiliki, Cristian R. Munteanu, Christoph Steinbeck, and Egon L. Willighagen. eNanoMapper: harnessing ontologies to enable data integration for nanomaterial risk assessment.Journal of Biomedical Semantics, 6:10, 2015. doi: 10.1186/s13326-015-0005-5. URLhttps://doi.org/10.1186/s13326-015-0005-5

    work page doi:10.1186/s13326-015-0005-5 2015

  43. [43]

    Nature Machine Intelligence1(5), 206–215 (May 2019).https: //doi.org/10.1038/s42256-019-0048-x,https://www.nature.com/articles/s42256-019- 0048-x2

    Cynthia Rudin. Stop Explaining Black Box Machine Learning Models for High Stakes Decisions and Use Interpretable Models Instead.Nature Machine Intelligence, 1:206–215, 2019. doi: 10.1038/s42256-019-0048-x. URLhttps://doi.org/10.1038/s42256-019-0048-x

    work page doi:10.1038/s42256-019-0048-x 2019

  44. [44]

    Department of Health and Human Services

    U.S. Department of Health and Human Services. Summary of the HIPAA Privacy Rule. Online guidance, 2025. URL https://www.hhs.gov/hipaa/for-professionals/privacy/laws-r egulations/index.html. Accessed 28 April, 2026

    work page 2025

  45. [45]

    Regulation (EU) 2016/679 of the European Parliament and of the Council: General Data Protection Regulation

    European Parliament and Council of the European Union. Regulation (EU) 2016/679 of the European Parliament and of the Council: General Data Protection Regulation. Official Journal of the European Union, 2016. URL https://eur-lex.europa.eu/eli/reg/2016/679/oj . Accessed 28 April, 2026

    work page 2016

  46. [46]

    Roth, Shadi Albarqouni, Spyridon Bakas, Mathieu N

    Nicola Rieke, Jonny Hancox, Wenqi Li, Fausto Milletar` ı, Holger R. Roth, Shadi Albarqouni, Spyridon Bakas, Mathieu N. Galtier, Bennett A. Landman, Klaus Maier-Hein, Sebastien Ourselin, Micah Sheller, Ronald M. Summers, Andrew Trask, Daguang Xu, Maximilian Baust, and M. Jorge Cardoso. The future of digital health with federated learning.NPJ Digital Medici...

    work page doi:10.1038/s41746-020-00323-1 2020

  47. [47]

    Andersen, Rickard Armiento, Evgeny Blokhin, Gareth J

    Casper W. Andersen, Rickard Armiento, Evgeny Blokhin, Gareth J. Conduit, Shyam Dwaraknath, Matthew L. Evans, ´Ad´ am Fekete, Abhijith Gopakumar, Saulius Graˇ zulis, Andrius Merkys, Fawzi Mohamed, Giovanni Pizzi, Gian-Marco Rignanese, Markus Scheidgen, Leopold Talirz, Cormac Toher, Donald Winston, et al. OPTIMADE, an API for Exchanging Materials Data.Scien...

    work page doi:10.1038/s41597-021-00974-z 2021

  48. [48]

    Why should I trust you?

    Marco Tulio Ribeiro, Sameer Singh, and Carlos Guestrin. “Why Should I Trust You?”: Explaining the Predictions of Any Classifier. InProceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, pages 1135–1144. Association for Computing Machinery, 2016. doi: 10.1145/2939672.2939778. URL https://doi.org/10.1145/2939672.2939778

    work page doi:10.1145/2939672.2939778 2016

  49. [49]

    Lundberg and Su-In Lee

    Scott M. Lundberg and Su-In Lee. A Unified Approach to Interpreting Model Predictions. InAdvances in Neural Information Processing Systems 30, pages 4765–4774, 2017. URL https://proceedings.neurips.cc/paper_files/paper/2017/hash/8a20a8621978632d7 6c43dfd28b67767-Abstract.html. 34

    work page 2017

  50. [50]

    Department of Health and Human Services

    U.S. Department of Health and Human Services. Summary of the HIPAA Security Rule. Online guidance, 2024. URL https://www.hhs.gov/hipaa/for-professionals/security/laws-r egulations/index.html. Accessed 28 April, 2026

    work page 2024

  51. [51]

    Parallel Bayesian Optimization of Multiple Noisy Objectives with Expected Hypervolume Improvement.Advances in Neural Information Processing Systems, 34:2187–2200, 2021

    Samuel Daulton, Maximilian Balandat, and Eytan Bakshy. Parallel Bayesian Optimization of Multiple Noisy Objectives with Expected Hypervolume Improvement.Advances in Neural Information Processing Systems, 34:2187–2200, 2021. URL https://proceedings.neurips. cc/paper/2021/hash/11704817e347269b7254e744b5e22dac-Abstract.html

    work page arXiv 2021

  52. [52]

    2019 , month =

    Claudia Draxl and Matthias Scheffler. The NOMAD Laboratory: From Data Sharing to Artificial Intelligence.Journal of Physics: Materials, 2(3):036001, 2019. doi: 10.1088/2515-7639/ab13bb. URLhttps://doi.org/10.1088/2515-7639/ab13bb

    work page doi:10.1088/2515-7639/ab13bb 2019

  53. [53]

    Manners, James Blackshaw, Sybilla Corbett, Marleen de Veij, Haris Ioannidis, David Mendez Lopez, Juan F

    Barbara Zdrazil, Eloy Felix, Fiona Hunter, Emma J. Manners, James Blackshaw, Sybilla Corbett, Marleen de Veij, Haris Ioannidis, David Mendez Lopez, Juan F. Mosquera, Maria Paula Magarinos, Nicolas Bosc, Ricardo Arcila, Tunca Kiziloren, Anna Gaulton, A. Patricia Bento, et al. The ChEMBL database in 2023: a drug discovery platform spanning multiple bioactiv...

    work page doi:10.1093/nar/gkad1004 2023

  54. [54]

    Klann, Matthew A

    Jeffrey G. Klann, Matthew A. H. Joss, Kevin Embree, and Shawn N. Murphy. Data model harmonization for the All Of Us Research Program: transforming i2b2 data into the OMOP common data model.PLOS ONE, 14(2):e0212463, 2019. doi: 10.1371/journal.pone.0212463. URLhttps://doi.org/10.1371/journal.pone.0212463

    work page doi:10.1371/journal.pone.0212463 2019

  55. [55]

    Munteanu, Haralambos Sarimveis, Bart Smeets, Pantelis Sopasakis, Georgia Tsiliki, David Vorgrimmler, Egon L

    Nina Jeliazkova, Charalampos Chomenidis, Philip Doganis, Bengt Fadeel, Roland Grafstr¨ om, Barry Hardy, Janna Hastings, Markus Hegi, Vedrin Jeliazkov, Nikolay Kochev, Pekka Kohonen, Cristian R. Munteanu, Haralambos Sarimveis, Bart Smeets, Pantelis Sopasakis, Georgia Tsiliki, David Vorgrimmler, Egon L. Willighagen, et al. The eNanoMapper database for nanom...

    work page doi:10.3762/bjnano.6.165 2015

  56. [56]

    Williams

    David F. Williams. On the mechanisms of biocompatibility.Biomaterials, 29(20):2941–2953,

    work page

  57. [57]

    URL https://doi.org/10.1016/j.biomater ials.2008.04.023

    doi: 10.1016/j.biomaterials.2008.04.023. URL https://doi.org/10.1016/j.biomater ials.2008.04.023

    work page doi:10.1016/j.biomaterials.2008.04.023 2008

  58. [58]

    Roth, Aoxiao Zhong, Arash Harouni, Amilcare Gentili, A

    Ittai Dayan, Holger R. Roth, Aoxiao Zhong, Arash Harouni, Amilcare Gentili, A. Z. Abidin, Andrew Liu, Anthony Beards Costa, Bradford J. Wood, Chien-Sung Tsai, et al. Federated learning for predicting clinical outcomes in patients with COVID-19.Nature Medicine, 27: 1735–1743, 2021. doi: 10.1038/s41591-021-01506-3. URL https://doi.org/10.1038/s41591 -021-01506-3

    work page doi:10.1038/s41591-021-01506-3 2021

  59. [59]

    Artificial intelligence risk management framework (ai rmf 1.0),

    Elham Tabassi. Artificial Intelligence Risk Management Framework (AI RMF 1.0). Technical Report NIST AI 100-1, National Institute of Standards and Technology, 2023. URL https: //doi.org/10.6028/NIST.AI.100-1. 35

    work page doi:10.6028/nist.ai.100-1 2023